drugset
drugset / Trial / NCT06090136

Safety and Pharmacokinetics of a Single Oral TPN171H in Healthy Elderly Subjects

NCT06090136 ↗

Phase 1 Completed 12 enrolled Vigonvita Life Sciences
NaSingle-groupOpen-labelTreatment

Summary

It is a single-center, open-label, Phase I clinical study evaluating the safety and pharmacokinetics of a single oral TPN171H in elderly subjects.

Timeline

Start
2020-09-14
Primary completion
2020-12-14
Completion
2022-07-22

Drugs

EvaluationDrugModalityDoseRoute
Subject TPN171H Unknown 5 mg Oral

Indications

erectile dysfunction